New CPG: Primary immunodeficiences
Primary immunodeficiencies (PIDs) is a new CPG and will be considered for endorsement by PIC in April 2021.
Primary immunodeficiencies (PIDs) is a new CPG and will be considered for endorsement by PIC in April 2021.
Nitrous Oxide misuse is a new CPG and will be considered for Victorian endorsement by PIC in April 2021.
Petechiae and purpura was an existing RCH CPG and will be considered for endorsement by PIC in April 2021. The revision was discussed by the CPG committee on 9 November 2020.
Anaphylaxis was an existing Victorian CPG and will be considered for endorsement by PIC in April 2021.
Community acquired needlestick injury was an existing Victorian CPG and will be considered for endorsement by PIC in April 2021. The revision was considered by the CPG committee on 15 June 2020.
Acute asthma was an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The revision was considered by interstate reviewers.
Henoch-schönlein purpura was an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The revision was considered by interstate reviewers.
Nasogastric fluids is a new CPG and was endorsed by PIC on 18 February 2021. The guideline was discussed by the CPG committee on 21 October 2020.
Gastroenteritis is an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The guideline was discussed by the CPG committee on 5 November 2020.
Vomiting is a new CPG and was endorsed by PIC on 18 February 2021. The guideline was discussed by the CPG committee on 16 September 2020.